Pulmonary Vascular Disease and Cardiac Performance in Extreme Preterm Infants (NCT04114435)

🧪 Interventions in This Study

• Echocardiography (OTHER)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Mcgill University Health Centre — Montreal, Quebec

📞 Contact the Study Coordinator

Phone: (514) 412-4452

Email: gabriel.altit@mail.mcgill.ca

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Prematurity; Extreme

• Assessment of Renal Function in Adults Born Preterm: The HAPI-Kidney Study — Montreal, Quebec
• Respiratory Outcomes After Early Vitamin D Supplementation in Infants Born Extremely Preterm — Birmingham, Alabama
• Early Protein Supplementation in Extremely Preterm Infants Fed Human Milk — Birmingham, Alabama
• Targeted Fortification of Donor Breast Milk in Preterm Infants — New York, New York

Explore by condition: All Prematurity; Extreme clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.